Objective: To evaluate the oral hypoglycemic agents used in our hospital.
目的：了解我院口服降血糖药的使用情况。
Now commonly used oral hypoglycemic agents are glucophage, glibenclamide and so on.
目前常用的口服降糖药有双胍类、磺脲类、噻磋烷二酮类等。
CONCLUSION The use of oral hypoglycemic drugs is approximate stable in recent 3 years.
结论我院近3年口服降血糖药物应用基本稳定。
OBJECTIVE To provide the information for rational administer of oral hypoglycemic drugs.
目的为临床合理应用口服降血糖药提供信息。
At the same time two groups of patients had oral hypoglycemic drugs and insulin therapy.
同时两组患者均口服降糖药物和胰岛素治疗。
Conclusion the drug utilization of oral hypoglycemic agents in our hospital is rational on the whole.
结论我院口服降糖药物利用药基本合理。
Method: The frequency and sum of money in consumption of oral hypoglycemic agents during 1998-2002 were analysed.
方法：对我院1998 ~ 2002年口服降血糖药的应用频率、消耗金额进行统计分析。
OBJECTIVE: To evaluate the status quo and developmental trend of the use of oral hypoglycemic drugs in guangdong area.
前言： 目的：评价广东地区口服降糖药应用现状及趋势。
In patients with type 2 diabetes, inhaled insulin may be used alone, along with oral hypoglycemic agents or with longer-acting insulins.
对于第二型糖尿病病患而言，吸入型胰岛素可以单独使用，或是与口服降血糖药物或是长效胰岛素并用。
Objective to evaluate the compliance of type 2 diabetes (2dm) treated with oral hypoglycemic agents (OHA) and analyze its influence factors.
目的评价2型糖尿病患者口服降糖药物(OHA)治疗的依从性水平并探讨其影响因素。
Objective: to realize the actuality of using oral hypoglycemic drug in our Hospital, and to provide reference standard for clinical rational use.
目的：了解我院口服降糖药使用现状，为临床合理使用提供参考。
METHODS: to give an account of research progress in oral hypoglycemic agents and to give the clinical evaluation on newly developed oral hypoglycemic agents.
方法：介绍口服降血糖药的研究进展，对几种新型口服降血糖药进行临床应用评价。
RESULTS the varieties quantities and sales volumes of hypoglycemic drugs increased year by year, while oral hypoglycemic drugs were the leading drugs in our hospital.
结果我院降血糖药品种、数量及销售金额逐年增长，其中以口服降血糖药为主导用药。
Objective: To introduce the types and main roles of oral hypoglycemic drugs, emphasizing on the action mechanism and developmental trends of insulin sensitizing agent.
目的：介绍口服降糖药物的种类和主要作用，重点介绍胰岛素抵抗改善药物的作用机制和开发动态。
Insulin secretagogues presently is not only a kind of major oral hypoglycemic drugs but also the first-line treatment for non-obese and obese type 2 diabetic mellitus(T2DM).
胰岛素促泌剂是目前治疗2型糖尿病的一类主要口服降糖药，是非肥胖及部分肥胖2型糖尿病的一线治疗药物。
There is an increasing demand of patients for use of the natural products with anti-diabetic activity due to the side effects associated with the use of insulin and oral hypoglycemic agents.
由于胰岛素和口服化学合成药存在副作用，使得天然降血糖药日益受到糖尿病患者的青睐。
Objective: To investigate the physicochemical properties and hypoglycemic effect of insulin? Loaded nanoparticles (ins? NP) upon rats after oral administration.
目的：研究口服胰岛素毫微球(INS ？NP)的理化性能及对大鼠的降血糖作用。
Objective: To investigate the physicochemical properties and hypoglycemic effect of insulin? Loaded nanoparticles (ins? NP) upon rats after oral administration.
目的：研究口服胰岛素毫微球(INS ？NP)的理化性能及对大鼠的降血糖作用。
应用推荐